| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 68.60B | 62.95B | 58.41B | 49.68B | 39.79B | 32.55B |
| Gross Profit | 24.78B | 22.55B | 19.25B | 14.82B | 10.24B | 9.12B |
| EBITDA | 13.26B | 12.33B | 10.19B | 7.45B | 4.25B | 3.97B |
| Net Income | 5.07B | 4.89B | 4.42B | 3.32B | 1.75B | 1.95B |
Balance Sheet | ||||||
| Total Assets | 106.73B | 104.80B | 82.78B | 67.25B | 50.30B | 38.01B |
| Cash, Cash Equivalents and Short-Term Investments | 14.05B | 15.07B | 9.46B | 8.41B | 8.18B | 10.38B |
| Total Debt | 55.26B | 58.19B | 41.42B | 32.44B | 19.65B | 8.49B |
| Total Liabilities | 73.37B | 74.24B | 56.18B | 44.21B | 29.49B | 18.79B |
| Stockholders Equity | 33.73B | 30.86B | 26.76B | 23.04B | 20.82B | 19.22B |
Cash Flow | ||||||
| Free Cash Flow | 1.96B | -10.47B | -8.64B | -10.82B | -11.66B | -1.21B |
| Operating Cash Flow | 3.48B | -7.39B | -4.69B | -9.20B | -10.41B | -159.40M |
| Investing Cash Flow | 879.20M | -5.23B | -1.09B | -1.44B | -29.30M | -4.65B |
| Financing Cash Flow | -3.70B | 15.09B | 8.00B | 11.82B | 9.50B | 5.99B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ₹138.44B | 48.62 | ― | 0.23% | 40.14% | 53.51% | |
66 Neutral | ₹213.02B | 39.78 | ― | 0.50% | 11.85% | -3.66% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
58 Neutral | ₹24.28B | 49.64 | ― | ― | 483.21% | ― | |
58 Neutral | ₹8.19B | 25.40 | ― | 0.47% | 39.01% | -42.51% | |
51 Neutral | ₹199.33B | 29.09 | ― | 0.11% | ― | ― |